Eli Lilly advanced 2% after its weight loss pill orforglipron showed 10.5% average weight loss in a late-stage trial, versus 2.2% for placebo at 72 weeks.
Join our Mailing list!
Sign up to get all the latest financial news and business updates.
Please fill in the form and we will get in touch with you shortly and help answer any questions you may have about Offshore Supporting services.
